Shanrong Biotechnology Corp.
SRBT
$0.3216
-$0.3284-50.52%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.90K | 8.80K | 12.30K | -- | 61.60K |
| Total Receivables | 87.30K | 125.50K | 286.30K | 122.70K | 136.70K |
| Inventory | -- | -- | -- | 100.00K | 100.00K |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.50K | 12.10K | 7.90K | -- | 7.90K |
| Total Current Assets | 127.60K | 146.30K | 306.40K | 406.80K | 306.10K |
|
|
|||||
| Total Current Assets | 127.60K | 146.30K | 306.40K | 406.80K | 306.10K |
| Net Property, Plant & Equipment | 62.90K | 71.80K | 80.70K | 89.60K | 98.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 190.50K | 218.20K | 387.10K | 496.40K | 404.70K |
|
|
|||||
| Total Accounts Payable | 669.20K | 649.90K | 1.17M | 824.00K | 560.40K |
| Total Accrued Expenses | 1.29M | 1.21M | 1.18M | 1.17M | 901.70K |
| Short-term Debt | 1.01M | 945.50K | 1.04M | 1.48M | 1.45M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.09M | 1.29M | 1.05M | 1.07M | 1.10M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 51.60K | 100.00 |
| Total Other Current Liabilities | -- | -- | -- | 51.60K | 100.00 |
| Total Current Liabilities | 4.05M | 4.09M | 4.44M | 4.59M | 4.01M |
|
|
|||||
| Total Current Liabilities | 4.05M | 4.09M | 4.44M | 4.59M | 4.01M |
| Long-Term Debt | 114.00K | -- | -- | -- | -- |
| Short-term Debt | 1.01M | 945.50K | 1.04M | 1.48M | 1.45M |
| Capital Leases | 3.50K | 11.80K | 22.20K | 33.40K | 43.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.17M | 4.11M | 4.46M | 4.62M | 4.06M |
|
|
|||||
| Common Stock & APIC | 5.53M | 1.94M | 1.94M | 1.31M | 1.29M |
| Retained Earnings | -10.42M | -6.35M | -6.53M | -6.09M | -5.34M |
| Treasury Stock & Other | 910.00K | 525.00K | 525.00K | 650.00K | 400.00K |
| Total Common Equity | -3.98M | -3.89M | -4.07M | -- | -3.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.98M | -3.89M | -4.07M | -- | -3.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.98M | -3.89M | -4.07M | -- | -3.65M |
|
|
|||||
